FDA issues warning on GLP-1 drugs over rare eye condition causing sudden blindness
The FDA has added a warning to all GLP-1 agonist labels about a rare eye condition, nonarteritic anterior ischemic optic neuropathy, that could cause sudden permanent blindness.